BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123418
Published online Jan 21, 2027. doi: 10.3748/wjg.123418
Figure 1
Figure 1 Treatment patterns and colectomy rates stratified by ulcerative colitis disease activity at diagnosis. A: Cumulative medication exposure in patients with mild-to-moderate ulcerative colitis (UC); B: Cumulative medication exposure in patients with moderate-to-severe UC; C: Sequencing of advanced therapies in patients with mild-to-moderate UC; D: Sequencing of advanced therapies in patients with moderate-to-severe UC; E: Cumulative incidence of colectomy according to baseline disease activity. 5-ASA: 5-aminosalicylate.
Figure 2
Figure 2 Clinical and treatment-related factors associated with colectomy risk in ulcerative colitis. Forest plot of univariable and multivariable Cox regression analyses evaluating clinical and treatment-related factors associated with colectomy in patients with ulcerative colitis. 1These variables were included as time-varying covariates. CI: Confidence interval; E1: Proctitis; E2: Left-sided colitis; E3: Extensive colitis; HR: Hazard ratio; Ref: Reference.


Write to the Help Desk